| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2021 | A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes | Wang, Yu-Hung; Hou, Hsin-An; Lin, Chien-Chin; Kuo, Yuan-Yeh; CHI-YUAN YAO; Hsu, Chia-Lang; Tseng, Mei-Hsuan; Tsai, Cheng-Hong; Peng, Yen-Ling; Kao, Chein-Jun; WEN-CHIEN CHOU ; Tien, Hwei-Fang | Blood advances | | 0 | |
| 2021 | A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes | Wang, Yu-Hung; Hou, Hsin-An; Lin, Chien-Chin; Kuo, Yuan-Yeh; CHI-YUAN YAO ; Hsu, Chia-Lang; Tseng, Mei-Hsuan; Tsai, Cheng-Hong; Peng, Yen-Ling; Kao, Chein-Jun; Chou, Wen-Chien; Tien, Hwei-Fang | Blood advances | | | |
| 2021 | A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes | Wang, Yu-Hung; Hou, Hsin-An; CHIEN-CHIN LIN ; Kuo, Yuan-Yeh; Yao, Chi-Yuan; Hsu, Chia-Lang; Tseng, Mei-Hsuan; Tsai, Cheng-Hong; Peng, Yen-Ling; Kao, Chein-Jun; Chou, Wen-Chien; Tien, Hwei-Fang | Blood advances | | 0 | |
| 2021 | A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes | Wang, Yu-Hung; Hou, Hsin-An; Lin, Chien-Chin; Kuo, Yuan-Yeh; CHI-YUAN YAO; Hsu, Chia-Lang; Tseng, Mei-Hsuan; Tsai, Cheng-Hong; Peng, Yen-Ling; Kao, Chein-Jun; Chou, Wen-Chien; HWEI-FANG TIEN | Blood advances | | 0 | |
| 2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | Tsai, Cheng-Hong; Tang, Jih-Luh; Tien, Feng-Ming; Kuo, Yuan-Yeh; Wu, Dung-Chi; Lin, Chien-Chin; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; Lin, Liang-In; WEN-CHIEN CHOU ; Chen, Chien-Yu; Hou, Hsin-An; Tien, Hwei-Fang; MING YAO | Blood advances | | 7 | |
| 2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | Tsai, Cheng-Hong; Tang, Jih-Luh; Tien, Feng-Ming; Kuo, Yuan-Yeh; Wu, Dung-Chi; Lin, Chien-Chin; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; MING YAO ; Lin, Liang-In; Chou, Wen-Chien; Chen, Chien-Yu; Hou, Hsin-An; Tien, Hwei-Fang | Blood advances | | 7 | |
| 2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | Tsai, Cheng-Hong; Tang, Jih-Luh; Tien, Feng-Ming; Kuo, Yuan-Yeh; Wu, Dung-Chi; Lin, Chien-Chin; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; Chou, Wen-Chien; Chen, Chien-Yu; Hou, Hsin-An; MING YAO; Tien, Hwei-Fang | Blood advances | | 7 | |
| 2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | Tsai, Cheng-Hong; Tang, Jih-Luh; TIEN FENG-MING; Kuo, Yuan-Yeh; Wu, Dung-Chi; CHIEN-CHIN LIN ; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; MING YAO; Lin, Liang-In; Chou, Wen-Chien; Chen, Chien-Yu; Hou, Hsin-An; Tien, Hwei-Fang | Blood advances | | 7 | |
| 2021 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | TIEN FENG-MING; Tsai, Cheng-Hong; Huang, Sheng-Chuan; LIU JIA-HAU; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; Wu, Shang-Ju; SZU-CHUN HSU ; Ko, Bor-Sheng; Chou, Wen-Chien; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; Tien, Hwei-Fang | Bone marrow transplantation | 0 | 0 | |
| 2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | TIEN FENG-MING; Tsai, Cheng-Hong; Huang, Sheng-Chuan; LIU JIA-HAU; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; SHANG-JU WU ; SZU-CHUN HSU; Ko, Bor-Sheng; Chou, Wen-Chien; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; Tien, Hwei-Fang | Bone marrow transplantation | 0 | 0 | |
| 2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | Tien, Feng-Ming; Tsai, Cheng-Hong; Huang, Sheng-Chuan; Liu, Jia-Hau; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; Wu, Shang-Ju; SZU-CHUN HSU; Ko, Bor-Sheng; WEN-CHIEN CHOU ; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; Tien, Hwei-Fang | Bone marrow transplantation | | 0 | |
| 2021 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | Tien, Hwei-Fang; TIEN, FENG-MING; Tsai, Cheng-Hong; Huang, Sheng-Chuan; LIU JIA-HAU; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; LIANG-IN LIN ; Wu, Yu-Sin; Hou, Mei-Fang; Wu, Shang-Ju; SZU-CHUN HSU; Ko, Bor-Sheng; Chou, Wen-Chien; MING YAO; Hou, Hsin-An; Tang, Jih-Luh | Bone marrow transplantation | | 0 | |
| 2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | TIEN FENG-MING; Tsai, Cheng-Hong; Huang, Sheng-Chuan; LIU JIA-HAU; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; Wu, Shang-Ju; SZU-CHUN HSU; Ko, Bor-Sheng; Chou, Wen-Chien; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; HWEI-FANG TIEN | Bone marrow transplantation | | 0 | |
| 2018 | GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia | Tien, Feng-Ming; Hou, Hsin-An; Tsai, Cheng-Hong; Tang, Jih-Luh; Chiu, Yu-Chiao; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Lin, Chien-Ting; Wu, Shang-Ju; Ko, Bor-Sheng; Hsu, Szu-Chun; Huang, Shang-Yi; Yao, Ming; Chou, Wen-Chien; Tien, Hwei-Fang; CHI-TE LIU | Blood Cancer Journal | 7 | 20 | |
| 2019 | Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients | Tsai, Cheng-Hong; CHI-YUAN YAO ; Tien, Feng-Min; Tang, Jih-Luh; Kuo, Yuan-Yeh; Chiu, Yu-Chiao; Lin, Chien-Chin; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; MING YAO; Lin, Liang-In; Chou, Wen-Chien; Chen, Chien-Yu; Hou, Hsin-An; Tien, Hwei-Fang | EBioMedicine | 12 | 13 | |
